Jazz Pharmaceuticals 483, May 2012

Jazz Pharmaceuticals 483, May 2012

Peter Baker FDA, Jennifer Johnson FDA$119.00

FDA investigators audited the Jazz Pharmaceuticals facility in Palo Alto, CA, United States and issued inspectional observations (via FDA 483) on 30 May 2012.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 30 May 2012
  • Location: Palo Alto, United States